Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML.
El Chaer F, Borate U, Duléry R, Holtan SG, Law AD, Muffly L, Nassereddine S, Shallis RM, Stringaris K, Taylor J, Devine SM, Mohty M, Hourigan CS.
El Chaer F, et al.
Blood Adv. 2021 Mar 23;5(6):1757-1759. doi: 10.1182/bloodadvances.2020003839.
Blood Adv. 2021.
PMID: 33755090
Free PMC article.
No abstract available.